Conduit Pharmaceuticals Stock (NASDAQ:CDT)
Previous Close
$0.09
52W Range
$0.08 - $7.83
50D Avg
$0.11
200D Avg
$1.54
Market Cap
$9.28M
Avg Vol (3M)
$12.75M
Beta
2.12
Div Yield
-
CDT Company Profile
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.